{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:45:30Z","timestamp":1788561930655,"version":"build-2803163510"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1007\/s10286-019-00611-1","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T22:51:58Z","timestamp":1557960718000},"page":"277-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Autoimmune autonomic neuropathies and ganglionopathies: epidemiology, pathophysiology, and therapeutic advances"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3465-3590","authenticated-orcid":false,"given":"Elisabeth P.","family":"Golden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7799-8495","authenticated-orcid":false,"given":"Steven","family":"Vernino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,15]]},"reference":[{"key":"611_CR1","first-page":"355","volume":"94","author":"RR Young","year":"1969","unstructured":"Young RR, Asbury AK, Adams RD, Corbett JL (1969) Pure pan-dysautonomia with recovery. Trans Am Neurol Assoc 94:355\u2013357","journal-title":"Trans Am Neurol Assoc"},{"issue":"4","key":"611_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/brain\/98.4.613","volume":"98","author":"RR Young","year":"1975","unstructured":"Young RR, Asbury AK, Corbett JL, Adams RD (1975) Pure pan-dysautonomia with recovery. Description and discussion of diagnostic criteria. Brain J Neurol 98(4):613\u2013636","journal-title":"Brain J Neurol"},{"issue":"9","key":"611_CR3","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1212\/WNL.44.9.1675","volume":"44","author":"GA Suarez","year":"1994","unstructured":"Suarez GA, Fealey RD, Camilleri M, Low PA (1994) Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology 44(9):1675\u20131682","journal-title":"Neurology"},{"issue":"6","key":"611_CR4","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/ana.10556","volume":"53","author":"CM Klein","year":"2003","unstructured":"Klein CM, Vernino S, Lennon VA, Sandroni P, Fealey RD, Benrud-Larson L, Sletten D, Low PA (2003) The spectrum of autoimmune autonomic neuropathies. Ann Neurol 53(6):752\u2013758. https:\/\/doi.org\/10.1002\/ana.10556","journal-title":"Ann Neurol"},{"issue":"3","key":"611_CR5","doi-asserted-by":"publisher","first-page":"e0118312","DOI":"10.1371\/journal.pone.0118312","volume":"10","author":"S Nakane","year":"2015","unstructured":"Nakane S, Higuchi O, Koga M, Kanda T, Murata K, Suzuki T, Kurono H, Kunimoto M, Kaida K, Mukaino A, Sakai W, Maeda Y, Matsuo H (2015) Clinical features of autoimmune autonomic ganglionopathy and the detection of subunit-specific autoantibodies to the ganglionic acetylcholine receptor in Japanese patients. PLoS One 10(3):e0118312. https:\/\/doi.org\/10.1371\/journal.pone.0118312","journal-title":"PLoS One"},{"issue":"4","key":"611_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/jnnp-2016-314707","volume":"88","author":"S Nakane","year":"2017","unstructured":"Nakane S, Mukaino A, Maeda Y, Higuchi O, Matsuo H, Ando Y (2017) Extra-autonomic manifestations in autoimmune autonomic ganglionopathy: a Japanese survey. J Neurol Neurosurg Psychiatry 88(4):367\u2013368. https:\/\/doi.org\/10.1136\/jnnp-2016-314707","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"611_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1001\/archneurol.2009.78","volume":"66","author":"A McKeon","year":"2009","unstructured":"McKeon A, Lennon VA, Lachance DH, Fealey RD, Pittock SJ (2009) Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. Arch Neurol 66(6):735\u2013741. https:\/\/doi.org\/10.1001\/archneurol.2009.78","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"611_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.autneu.2008.10.016","volume":"146","author":"SK Baker","year":"2009","unstructured":"Baker SK, Morillo C, Vernino S (2009) Autoimmune autonomic ganglionopathy with late-onset encephalopathy. Auton Neurosci 146(1\u20132):29\u201332. https:\/\/doi.org\/10.1016\/j.autneu.2008.10.016","journal-title":"Auton Neurosci"},{"issue":"6","key":"611_CR9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.braindev.2015.12.009","volume":"38","author":"I Kuki","year":"2016","unstructured":"Kuki I, Kawawaki H, Okazaki S, Hattori Y, Horino A, Higuchi O, Nakane S (2016) Autoimmune autonomic ganglionopathy in a pediatric patient presenting with acute encephalitis. Brain Dev 38(6):605\u2013608. https:\/\/doi.org\/10.1016\/j.braindev.2015.12.009","journal-title":"Brain Dev"},{"issue":"4","key":"611_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/archneurol.2011.2372","volume":"69","author":"CH Gibbons","year":"2012","unstructured":"Gibbons CH, Centi J, Vernino S, Freeman R (2012) Autoimmune autonomic ganglionopathy with reversible cognitive impairment. Arch Neurol 69(4):461\u2013466. https:\/\/doi.org\/10.1001\/archneurol.2011.2372","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"611_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.autneu.2008.12.013","volume":"146","author":"M Hayashi","year":"2009","unstructured":"Hayashi M, Ishii Y (2009) A Japanese case of autoimmune autonomic ganglionopathy (AAG) and a review of AAG cases in Japan. Auton Neurosci 146(1\u20132):26\u201328. https:\/\/doi.org\/10.1016\/j.autneu.2008.12.013","journal-title":"Auton Neurosci"},{"issue":"8","key":"611_CR12","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S0025-6196(12)60631-4","volume":"68","author":"PA Low","year":"1993","unstructured":"Low PA (1993) Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc 68(8):748\u2013752","journal-title":"Mayo Clin Proc"},{"issue":"18","key":"611_CR13","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1212\/WNL.0b013e3181bf995f","volume":"73","author":"K Kimpinski","year":"2009","unstructured":"Kimpinski K, Iodice V, Sandroni P, Fealey RD, Vernino S, Low PA (2009) Sudomotor dysfunction in autoimmune autonomic ganglionopathy. Neurology 73(18):1501\u20131506. https:\/\/doi.org\/10.1212\/WNL.0b013e3181bf995f","journal-title":"Neurology"},{"issue":"5","key":"611_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1001\/archneurol.2011.2143","volume":"69","author":"S Muppidi","year":"2012","unstructured":"Muppidi S, Scribner M, Gibbons CH, Adams-Huet B, Spaeth EB, Vernino S (2012) A unique manifestation of pupillary fatigue in autoimmune autonomic ganglionopathy. Arch Neurol 69(5):644\u2013648. https:\/\/doi.org\/10.1001\/archneurol.2011.2143","journal-title":"Arch Neurol"},{"issue":"4","key":"611_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/ana.410130407","volume":"13","author":"PA Low","year":"1983","unstructured":"Low PA, Dyck PJ, Lambert EH, Brimijoin WS, Trautmann JC, Malagelada JR, Fealey RD, Barrett DM (1983) Acute panautonomic neuropathy. Ann Neurol 13(4):412\u2013417. https:\/\/doi.org\/10.1002\/ana.410130407","journal-title":"Ann Neurol"},{"issue":"5","key":"611_CR16","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1212\/WNL.41.5.746","volume":"41","author":"EL Feldman","year":"1991","unstructured":"Feldman EL, Bromberg MB, Blaivas M, Junck L (1991) Acute pandysautonomic neuropathy. Neurology 41(5):746\u2013748","journal-title":"Neurology"},{"issue":"5","key":"611_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/archneur.1973.00490290074010","volume":"29","author":"O Appenzeller","year":"1973","unstructured":"Appenzeller O, Kornfeld M (1973) Acute pandysautonomia. Clinical and morphologic study. Arch Neurol 29(5):334\u2013339","journal-title":"Arch Neurol"},{"issue":"10","key":"611_CR18","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s00415-012-6458-x","volume":"259","author":"H Koike","year":"2012","unstructured":"Koike H, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Koyano S, Momoo T, Yuasa H, Mitake S, Higashihara M, Kaida K, Yamamoto D, Hisahara S, Shimohama S, Nakae Y, Johkura K, Vernino S, Sobue G (2012) The spectrum of clinicopathological features in pure autonomic neuropathy. J Neurol 259(10):2067\u20132075. https:\/\/doi.org\/10.1007\/s00415-012-6458-x","journal-title":"J Neurol"},{"issue":"12","key":"611_CR19","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/nejm200009213431204","volume":"343","author":"S Vernino","year":"2000","unstructured":"Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA (2000) Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 343(12):847\u2013855. https:\/\/doi.org\/10.1056\/nejm200009213431204","journal-title":"N Engl J Med"},{"issue":"1","key":"611_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jneuroim.2008.03.017","volume":"197","author":"S Vernino","year":"2008","unstructured":"Vernino S, Lindstrom J, Hopkins S, Wang Z, Low PA (2008) Characterization of ganglionic acetylcholine receptor autoantibodies. J Neuroimmunol 197(1):63\u201369. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.03.017","journal-title":"J Neuroimmunol"},{"issue":"6","key":"611_CR21","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1212\/WNL.50.6.1806","volume":"50","author":"S Vernino","year":"1998","unstructured":"Vernino S, Adamski J, Kryzer TJ, Fealey RD, Lennon VA (1998) Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 50(6):1806\u20131813","journal-title":"Neurology"},{"issue":"1\u20132","key":"611_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.autneu.2011.06.005","volume":"164","author":"MG Miglis","year":"2011","unstructured":"Miglis MG, Racela R, Kaufmann H (2011) Seropositive myasthenia and autoimmune autonomic ganglionopathy: cross reactivity or subclinical disease? Auton Neurosci 164(1\u20132):87\u201388. https:\/\/doi.org\/10.1016\/j.autneu.2011.06.005","journal-title":"Auton Neurosci"},{"issue":"22","key":"611_CR23","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1212\/01.wnl.0000263185.30294.61","volume":"68","author":"Z Wang","year":"2007","unstructured":"Wang Z, Low PA, Jordan J, Freeman R, Gibbons CH, Schroeder C, Sandroni P, Vernino S (2007) Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current. Neurology 68(22):1917\u20131921. https:\/\/doi.org\/10.1212\/01.wnl.0000263185.30294.61","journal-title":"Neurology"},{"issue":"10","key":"611_CR24","doi-asserted-by":"publisher","first-page":"5746","DOI":"10.1073\/pnas.96.10.5746","volume":"96","author":"W Xu","year":"1999","unstructured":"Xu W, Gelber S, Orr-Urtreger A, Armstrong D, Lewis RA, Ou CN, Patrick J, Role L, De Biasi M, Beaudet AL (1999) Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 96(10):5746\u20135751","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"611_CR25","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1172\/jci17429","volume":"111","author":"VA Lennon","year":"2003","unstructured":"Lennon VA, Ermilov LG, Szurszewski JH, Vernino S (2003) Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J Clin Investig 111(6):907\u2013913. https:\/\/doi.org\/10.1172\/jci17429","journal-title":"J Clin Investig"},{"issue":"3","key":"611_CR26","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1152\/jn.00408.2003","volume":"90","author":"S Vernino","year":"2003","unstructured":"Vernino S, Low PA, Lennon VA (2003) Experimental autoimmune autonomic neuropathy. J Neurophysiol 90(3):2053\u20132059. https:\/\/doi.org\/10.1152\/jn.00408.2003","journal-title":"J Neurophysiol"},{"issue":"1\u20132","key":"611_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.autneu.2007.05.005","volume":"137","author":"S Mukherjee","year":"2007","unstructured":"Mukherjee S, Vernino S (2007) Dysfunction of the pupillary light reflex in experimental autoimmune autonomic ganglionopathy. Auton Neurosci 137(1\u20132):19\u201326. https:\/\/doi.org\/10.1016\/j.autneu.2007.05.005","journal-title":"Auton Neurosci"},{"issue":"32","key":"611_CR28","doi-asserted-by":"publisher","first-page":"7037","DOI":"10.1523\/jneurosci.1485-04.2004","volume":"24","author":"S Vernino","year":"2004","unstructured":"Vernino S, Ermilov LG, Sha L, Szurszewski JH, Low PA, Lennon VA (2004) Passive transfer of autoimmune autonomic neuropathy to mice. J Neurosci 24(32):7037\u20137042. https:\/\/doi.org\/10.1523\/jneurosci.1485-04.2004","journal-title":"J Neurosci"},{"key":"611_CR29","doi-asserted-by":"publisher","unstructured":"Baker SK, Chow BM, Vernino SA (2014) Transient neonatal autoimmune autonomic ganglionopathy. Neurol Neuroimmunol Neuroinflamm 1(3):35. https:\/\/doi.org\/10.1212\/nxi.0000000000000035","DOI":"10.1212\/nxi.0000000000000035"},{"issue":"3","key":"611_CR30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/mus.24559","volume":"52","author":"Y Li","year":"2015","unstructured":"Li Y, Jammoul A, Mente K, Li J, Shields RW, Vernino S, Rae-Grant A (2015) Clinical experience of seropositive ganglionic acetylcholine receptor antibody in a tertiary neurology referral center. Muscle Nerve 52(3):386\u2013391. https:\/\/doi.org\/10.1002\/mus.24559","journal-title":"Muscle Nerve"},{"issue":"1\u20132","key":"611_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.autneu.2008.11.013","volume":"146","author":"CH Gibbons","year":"2009","unstructured":"Gibbons CH, Freeman R (2009) Antibody titers predict clinical features of autoimmune autonomic ganglionopathy. Auton Neurosci 146(1\u20132):8\u201312. https:\/\/doi.org\/10.1016\/j.autneu.2008.11.013","journal-title":"Auton Neurosci"},{"issue":"2","key":"611_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/archneurol.2007.60","volume":"65","author":"CH Gibbons","year":"2008","unstructured":"Gibbons CH, Vernino SA, Freeman R (2008) Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy. Arch Neurol 65(2):213\u2013217. https:\/\/doi.org\/10.1001\/archneurol.2007.60","journal-title":"Arch Neurol"},{"issue":"15","key":"611_CR33","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1056\/NEJMoa051719","volume":"353","author":"C Schroeder","year":"2005","unstructured":"Schroeder C, Vernino S, Birkenfeld AL, Tank J, Heusser K, Lipp A, Benter T, Lindschau C, Kettritz R, Luft FC, Jordan J (2005) Plasma exchange for primary autoimmune autonomic failure. N Engl J Med 353(15):1585\u20131590. https:\/\/doi.org\/10.1056\/NEJMoa051719","journal-title":"N Engl J Med"},{"key":"611_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/b978-0-444-53491-0.00025-0","volume":"117","author":"S Muppidi","year":"2013","unstructured":"Muppidi S, Vernino S (2013) Autoimmune autonomic failure. Handb Clin Neurol 117:321\u2013327. https:\/\/doi.org\/10.1016\/b978-0-444-53491-0.00025-0","journal-title":"Handb Clin Neurol"},{"issue":"23","key":"611_CR35","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1212\/WNL.0b013e3181a92b52","volume":"72","author":"V Iodice","year":"2009","unstructured":"Iodice V, Kimpinski K, Vernino S, Sandroni P, Fealey RD, Low PA (2009) Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy. Neurology 72(23):2002\u20132008. https:\/\/doi.org\/10.1212\/WNL.0b013e3181a92b52","journal-title":"Neurology"},{"issue":"1\u20132","key":"611_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.autneu.2008.11.001","volume":"146","author":"V Iodice","year":"2009","unstructured":"Iodice V, Kimpinski K, Vernino S, Sandroni P, Low PA (2009) Immunotherapy for autoimmune autonomic ganglionopathy. Auton Neurosci 146(1\u20132):22\u201325. https:\/\/doi.org\/10.1016\/j.autneu.2008.11.001","journal-title":"Auton Neurosci"},{"key":"611_CR37","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1212\/01.con.0000455875.76179.b1","volume":"20","author":"V Iodice","year":"2014","unstructured":"Iodice V, Sandroni P (2014) Autonomic neuropathies. Continuum (Minneapolis, Minn) 20:1373\u20131397. https:\/\/doi.org\/10.1212\/01.con.0000455875.76179.b1","journal-title":"Continuum (Minneapolis, Minn)"},{"issue":"4","key":"611_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10286-015-0299-5","volume":"25","author":"A Gupta","year":"2015","unstructured":"Gupta A, Harris S, Vernino S, Naina HV (2015) Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy. Clin Auton Res 25(4):255\u2013258. https:\/\/doi.org\/10.1007\/s10286-015-0299-5","journal-title":"Clin Auton Res"},{"issue":"4","key":"611_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10286-009-0012-7","volume":"19","author":"R Imrich","year":"2009","unstructured":"Imrich R, Vernino S, Eldadah BA, Holmes C, Goldstein DS (2009) Autoimmune autonomic ganglionopathy: treatment by plasma exchanges and rituximab. Clin Auton Res 19(4):259\u2013262. https:\/\/doi.org\/10.1007\/s10286-009-0012-7","journal-title":"Clin Auton Res"},{"issue":"3","key":"611_CR40","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1001\/archneurol.2010.289","volume":"68","author":"R Hollenbeck","year":"2011","unstructured":"Hollenbeck R, Black BK, Peltier AC, Biaggioni I, Robertson D, Winton EF, Raj SR (2011) Long-term treatment with rituximab of autoimmune autonomic ganglionopathy in a patient with lymphoma. Arch Neurol 68(3):372\u2013375. https:\/\/doi.org\/10.1001\/archneurol.2010.289","journal-title":"Arch Neurol"},{"key":"611_CR41","unstructured":"Benizri S, Agmon-Levin N, Kitrey ND, Carter D, Goshen E, Sharabi Y (2017) Clinical problem solving: a tobacco merchant who can\u2019t spit. Isr Med Assoc J 19(12):786\u2013791"},{"key":"611_CR42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jneuroim.2018.11.009","volume":"326","author":"M Bouxin","year":"2019","unstructured":"Bouxin M, Schvartz B, Mestrallet S, Debrumetz A, Hentzien M, Tabary T, Cohen R, Nicolas G, Bani-Sadr F (2019) Rituximab treatment in seronegative autoimmune autonomic neuropathy and autoimmune autonomic ganglionopathy: case-report and literature review. J Neuroimmunol 326:28\u201332. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.11.009","journal-title":"J Neuroimmunol"},{"key":"611_CR43","doi-asserted-by":"publisher","unstructured":"Dumitrascu OM, McKeon A, Zuniga L, Grill MF, Goodman BP (2017) Opsoclonus-myoclonus syndrome during rituximab treatment for autoimmune autonomic ganglionopathy. Neurol Neuroimmunol Neuroinflamm 4(5):e376. https:\/\/doi.org\/10.1212\/nxi.0000000000000376","DOI":"10.1212\/nxi.0000000000000376"},{"issue":"1","key":"611_CR44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1001\/archneur.61.1.44","volume":"61","author":"P Sandroni","year":"2004","unstructured":"Sandroni P, Vernino S, Klein CM, Lennon VA, Benrud-Larson L, Sletten D, Low PA (2004) Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody. Arch Neurol 61(1):44\u201348. https:\/\/doi.org\/10.1001\/archneur.61.1.44","journal-title":"Arch Neurol"},{"key":"611_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jneuroim.2018.03.018","volume":"319","author":"B Tijero","year":"2018","unstructured":"Tijero B, Del Pino R, Perez-Concha T, Acera MA, Gabilondo I, Berganzo K, Graus F, Martinez-Alday JD, Barcena J, Gomez-Esteban JC (2018) Seronegative and seropositive autoimmune autonomic ganglionopathy (AAG): same clinical picture, same response to immunotherapy. J Neuroimmunol 319:68\u201370. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.03.018","journal-title":"J Neuroimmunol"},{"issue":"1","key":"611_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10286-017-0493-8","volume":"28","author":"EP Golden","year":"2018","unstructured":"Golden EP, Bryarly MA, Vernino S (2018) Seronegative autoimmune autonomic neuropathy: a distinct clinical entity. Clin Auton Res 28(1):115\u2013123. https:\/\/doi.org\/10.1007\/s10286-017-0493-8","journal-title":"Clin Auton Res"},{"issue":"1","key":"611_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10286-017-0496-5","volume":"28","author":"S Muppidi","year":"2018","unstructured":"Muppidi S (2018) Autoimmune autonomic neuropathies: time to look beyond autoimmune autonomic ganglionopathy. Clin Auton Res 28(1):7\u20138. https:\/\/doi.org\/10.1007\/s10286-017-0496-5","journal-title":"Clin Auton Res"},{"issue":"20","key":"611_CR48","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1212\/01.wnl.0000312280.44805.5d","volume":"70","author":"S Vernino","year":"2008","unstructured":"Vernino S, Sandroni P, Singer W, Low PA (2008) Invited article: autonomic ganglia: target and novel therapeutic tool. Neurology 70(20):1926\u20131932. https:\/\/doi.org\/10.1212\/01.wnl.0000312280.44805.5d","journal-title":"Neurology"},{"key":"611_CR49","doi-asserted-by":"publisher","unstructured":"Mukaino A, Minami H, Isomoto H, Hamamoto H, Ihara E, Maeda Y, Higuchi O, Okanishi T, Kokudo Y, Deguchi K, Sasaki F, Ueki T, Murata KY, Yoshida T, Kinjo M, Ogawa Y, Ido A, Matsuo H, Nakao K, Nakane S (2018) Anti-ganglionic AChR antibodies in Japanese patients with motility disorders. J Gastroenterol 53(12):1227\u20131240. https:\/\/doi.org\/10.1007\/s00535-018-1477-8","DOI":"10.1007\/s00535-018-1477-8"},{"key":"611_CR50","doi-asserted-by":"crossref","unstructured":"Vernino S, Hopkins S, Okamoto L, Black B, Dorminy C, Paranjape S, Raj S (2015) Prevalence of ganglionic AChR antibodies in postural tachycardia syndrome (POTS) (P1.276). Neurology 84 (14 Suppl)","DOI":"10.1212\/WNL.84.14_supplement.P1.276"},{"key":"611_CR51","first-page":"328","volume":"26","author":"S Vernino","year":"2016","unstructured":"Vernino S, Bryarly M, Hopkins S, Okamoto LE, Black BK, Paranjape SY, Raj SR (2016) The prevalence of ganglionic AchR antibodies in postural tachycardia syndrome (POTS). Clin Auton Res 26:328","journal-title":"Clin Auton Res"},{"key":"611_CR52","doi-asserted-by":"publisher","unstructured":"Thieben MJ, Sandroni P, Sletten DM, Benrud-Larson LM, Fealey RD, Vernino S, Lennon VA, Shen WK, Low PA (2007) Postural orthostatic tachycardia syndrome: the Mayo Clinic experience. Mayo Clin Proc 82(3):308\u2013313. https:\/\/doi.org\/10.4065\/82.3.308","DOI":"10.4065\/82.3.308"},{"issue":"4","key":"611_CR53","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/acn3.524","volume":"5","author":"M Watari","year":"2018","unstructured":"Watari M, Nakane S, Mukaino A, Nakajima M, Mori Y, Maeda Y, Masuda T, Takamatsu K, Kouzaki Y, Higuchi O, Matsuo H, Ando Y (2018) Autoimmune postural orthostatic tachycardia syndrome. Ann Clin Trans Neurol 5(4):486\u2013492. https:\/\/doi.org\/10.1002\/acn3.524","journal-title":"Ann Clin Trans Neurol"},{"issue":"1","key":"611_CR54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00246-014-0981-8","volume":"36","author":"J Li","year":"2015","unstructured":"Li J, Zhang Q, Liao Y, Zhang C, Hao H, Du J (2015) The value of acetylcholine receptor antibody in children with postural tachycardia syndrome. Pediatr Cardiol 36(1):165\u2013170. https:\/\/doi.org\/10.1007\/s00246-014-0981-8","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"611_CR55","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/jnnp-2012-302833","volume":"84","author":"H Koike","year":"2013","unstructured":"Koike H, Watanabe H, Sobue G (2013) The spectrum of immune-mediated autonomic neuropathies: insights from the clinicopathological features. J Neurol Neurosurg Psychiatry 84(1):98\u2013106. https:\/\/doi.org\/10.1136\/jnnp-2012-302833","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"611_CR56","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/1346-8138.13649","volume":"44","author":"T Munetsugu","year":"2017","unstructured":"Munetsugu T, Fujimoto T, Oshima Y, Sano K, Murota H, Satoh T, Iwase S, Asahina M, Nakazato Y, Yokozeki H (2017) Revised guideline for the diagnosis and treatment of acquired idiopathic generalized anhidrosis in Japan. J Dermatol 44(4):394\u2013400. https:\/\/doi.org\/10.1111\/1346-8138.13649","journal-title":"J Dermatol"},{"issue":"4","key":"611_CR57","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/ana.410080419","volume":"8","author":"RV Colan","year":"1980","unstructured":"Colan RV, Snead OC 3rd, Oh SJ, Kashlan MB (1980) Acute autonomic and sensory neuropathy. Ann Neurol 8(4):441\u2013444. https:\/\/doi.org\/10.1002\/ana.410080419","journal-title":"Ann Neurol"},{"issue":"10","key":"611_CR58","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1093\/brain\/awq214","volume":"133","author":"H Koike","year":"2010","unstructured":"Koike H, Atsuta N, Adachi H, Iijima M, Katsuno M, Yasuda T, Fukada Y, Yasui K, Nakashima K, Horiuchi M, Shiomi K, Fukui K, Takashima S, Morita Y, Kuniyoshi K, Hasegawa Y, Toribe Y, Kajiura M, Takeshita S, Mukai E, Sobue G (2010) Clinicopathological features of acute autonomic and sensory neuropathy. Brain 133(10):2881\u20132896. https:\/\/doi.org\/10.1093\/brain\/awq214","journal-title":"Brain"},{"issue":"1","key":"611_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10286-008-0488-6","volume":"19","author":"S Vernino","year":"2009","unstructured":"Vernino S (2009) Antibody testing as a diagnostic tool in autonomic disorders. Clin Auton Res 19(1):13\u201319. https:\/\/doi.org\/10.1007\/s10286-008-0488-6","journal-title":"Clin Auton Res"},{"issue":"7","key":"611_CR60","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1053\/j.gastro.2004.02.024","volume":"126","author":"R De Giorgio","year":"2004","unstructured":"De Giorgio R, Guerrini S, Barbara G, Stanghellini V, De Ponti F, Corinaldesi R, Moses PL, Sharkey KA, Mawe GM (2004) Inflammatory neuropathies of the enteric nervous system. Gastroenterology 126(7):1872\u20131883","journal-title":"Gastroenterology"},{"issue":"5","key":"611_CR61","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1053\/j.gastro.2006.06.018","volume":"131","author":"SF Pasha","year":"2006","unstructured":"Pasha SF, Lunsford TN, Lennon VA (2006) Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. Gastroenterology 131(5):1592\u20131596. https:\/\/doi.org\/10.1053\/j.gastro.2006.06.018","journal-title":"Gastroenterology"},{"issue":"3","key":"611_CR62","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1212\/WNL.50.3.652","volume":"50","author":"CF Lucchinetti","year":"1998","unstructured":"Lucchinetti CF, Kimmel DW, Lennon VA (1998) Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 50(3):652\u2013657","journal-title":"Neurology"},{"issue":"2","key":"611_CR63","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","volume":"49","author":"Z Yu","year":"2001","unstructured":"Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA (2001) CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49(2):146\u2013154","journal-title":"Ann Neurol"},{"key":"611_CR64","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1212\/01.con.0000455876.53309.ec","volume":"20","author":"S Muppidi","year":"2014","unstructured":"Muppidi S, Vernino S (2014) Paraneoplastic neuropathies. Continuum (Minneapolis, Minn) 20:1359\u20131372. https:\/\/doi.org\/10.1212\/01.con.0000455876.53309.ec","journal-title":"Continuum (Minneapolis, Minn)"},{"key":"611_CR65","doi-asserted-by":"publisher","unstructured":"Titulaer MJ, Wirtz PW, Kuks JB, Schelhaas HJ, van der Kooi AJ, Faber CG, van der Pol WL, de Visser M, Sillevis Smitt PA, Verschuuren JJ (2008) The Lambert\u2013Eaton myasthenic syndrome 1988\u20132008: a clinical picture in 97 patients. J Neuroimmunol 201\u2013202:153\u2013158. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.05.025","DOI":"10.1016\/j.jneuroim.2008.05.025"},{"key":"611_CR66","doi-asserted-by":"crossref","unstructured":"Wirtz PW, Smallegange TM, Wintzen AR, Verschuuren JJ (2002) Differences in clinical features between the Lambert\u2013Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases. Clin Neurol Neurosurg 104(4):359\u2013363","DOI":"10.1016\/S0303-8467(02)00054-9"},{"key":"611_CR67","doi-asserted-by":"publisher","unstructured":"Lennon VA, Kryzer TJ, Griesmann GE, O\u2019Suilleabhain PE, Windebank AJ, Woppmann A, Miljanich GP, Lambert EH (1995) Calcium-channel antibodies in the Lambert\u2013Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 332(22):1467\u20131474. https:\/\/doi.org\/10.1056\/nejm199506013322203","DOI":"10.1056\/nejm199506013322203"},{"key":"611_CR68","doi-asserted-by":"publisher","unstructured":"Kesner VG, Oh SJ, Dimachkie MM, Barohn RJ (2018) Lambert\u2013Eaton myasthenic syndrome. Neurol Clin 36(2):379\u2013394. https:\/\/doi.org\/10.1016\/j.ncl.2018.01.008","DOI":"10.1016\/j.ncl.2018.01.008"},{"key":"611_CR69","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1212\/con.0000000000000520","volume":"23","author":"K Sawlani","year":"2017","unstructured":"Sawlani K, Katirji B (2017) Peripheral nerve hyperexcitability syndromes. Continuum (Minneapolis, Minn) 23:1437\u20131450. https:\/\/doi.org\/10.1212\/con.0000000000000520","journal-title":"Continuum (Minneapolis, Minn)"},{"issue":"2","key":"611_CR70","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ana.23577","volume":"72","author":"SR Irani","year":"2012","unstructured":"Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, Zuliani L, Watanabe O, Lang B, Buckley C, Vincent A (2012) Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72(2):241\u2013255. https:\/\/doi.org\/10.1002\/ana.23577","journal-title":"Ann Neurol"},{"issue":"1","key":"611_CR71","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.24979","volume":"82","author":"A Gadoth","year":"2017","unstructured":"Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, Smith A, Kotsenas AL, Watson RE, Lachance DH, Flanagan EP, Lennon VA, Klein CJ (2017) Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients. Ann Neurol 82(1):79\u201392. https:\/\/doi.org\/10.1002\/ana.24979","journal-title":"Ann Neurol"},{"issue":"6","key":"611_CR72","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/00004691-200411000-00008","volume":"21","author":"KA Josephs","year":"2004","unstructured":"Josephs KA, Silber MH, Fealey RD, Nippoldt TB, Auger RG, Vernino S (2004) Neurophysiologic studies in Morvan syndrome. J Clin Neurophysiol 21(6):440\u2013445","journal-title":"J Clin Neurophysiol"},{"key":"611_CR73","doi-asserted-by":"crossref","unstructured":"Singh NK, Jaiswal AK, Misra S, Srivastava PK (1987) Assessment of autonomic dysfunction in Guillain\u2013Barr\u00e9 syndrome and its prognostic implications. Acta Neurol Scand 75(2):101\u2013105","DOI":"10.1111\/j.1600-0404.1987.tb07902.x"},{"key":"611_CR74","doi-asserted-by":"publisher","unstructured":"Zaeem Z, Siddiqi ZA, Zochodne DW (2018) Autonomic involvement in Guillain\u2013Barr\u00e9 syndrome: an update. Clin Auton Res. https:\/\/doi.org\/10.1007\/s10286-018-0542-y","DOI":"10.1007\/s10286-018-0542-y"},{"issue":"2","key":"611_CR75","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/mus.25551","volume":"56","author":"C Anandan","year":"2017","unstructured":"Anandan C, Khuder SA, Koffman BM (2017) Prevalence of autonomic dysfunction in hospitalized patients with Guillain\u2013Barr\u00e9 syndrome. Muscle Nerve 56(2):331\u2013333. https:\/\/doi.org\/10.1002\/mus.25551","journal-title":"Muscle Nerve"},{"key":"611_CR76","doi-asserted-by":"publisher","unstructured":"van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA (2014) Guillain\u2013Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 10(8):469\u2013482. https:\/\/doi.org\/10.1038\/nrneurol.2014.121","DOI":"10.1038\/nrneurol.2014.121"},{"key":"611_CR77","doi-asserted-by":"publisher","unstructured":"Zochodne DW (1994) Autonomic involvement in Guillain\u2013Barr\u00e9 syndrome: a review. Muscle Nerve 17(10):1145\u20131155. https:\/\/doi.org\/10.1002\/mus.880171004","DOI":"10.1002\/mus.880171004"},{"issue":"3","key":"611_CR78","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00415-015-8002-2","volume":"263","author":"L Baysal-Kirac","year":"2016","unstructured":"Baysal-Kirac L, Tuzun E, Erdag E, Ulusoy C, Vanli-Yavuz EN, Ekizoglu E, Peach S, Sezgin M, Bebek N, Gurses C, Gokyigit A, Vincent A, Baykan B (2016) Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings. J Neurol 263(3):455\u2013466. https:\/\/doi.org\/10.1007\/s00415-015-8002-2","journal-title":"J Neurol"},{"issue":"12","key":"611_CR79","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/s1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091\u20131098. https:\/\/doi.org\/10.1016\/s1474-4422(08)70224-2","journal-title":"Lancet Neurol"},{"key":"611_CR80","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.autneu.2015.08.002","volume":"193","author":"JI Byun","year":"2015","unstructured":"Byun JI, Lee ST, Moon J, Jung KH, Shin JW, Sunwoo JS, Lim JA, Shin YW, Kim TJ, Lee KJ, Park KI, Jung KY, Lee SK, Chu K (2015) Cardiac sympathetic dysfunction in anti-NMDA receptor encephalitis. Auton Neurosci 193:142\u2013146. https:\/\/doi.org\/10.1016\/j.autneu.2015.08.002","journal-title":"Auton Neurosci"},{"issue":"20","key":"611_CR81","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1212\/wnl.0000000000000991","volume":"83","author":"WO Tobin","year":"2014","unstructured":"Tobin WO, Lennon VA, Komorowski L, Probst C, Clardy SL, Aksamit AJ, Appendino JP, Lucchinetti CF, Matsumoto JY, Pittock SJ, Sandroni P, Tippmann-Peikert M, Wirrell EC, McKeon A (2014) DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology 83(20):1797\u20131803. https:\/\/doi.org\/10.1212\/wnl.0000000000000991","journal-title":"Neurology"},{"issue":"10","key":"611_CR82","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/wnl.0000000000001907","volume":"85","author":"J Piepgras","year":"2015","unstructured":"Piepgras J, Holtje M, Michel K, Li Q, Otto C, Drenckhahn C, Probst C, Schemann M, Jarius S, Stocker W, Balint B, Meinck HM, Buchert R, Dalmau J, Ahnert-Hilger G, Ruprecht K (2015) Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons. Neurology 85(10):890\u2013897. https:\/\/doi.org\/10.1212\/wnl.0000000000001907","journal-title":"Neurology"},{"key":"611_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.autneu.2015.06.001","volume":"193","author":"JM Racosta","year":"2015","unstructured":"Racosta JM, Kimpinski K, Morrow SA, Kremenchutzky M (2015) Autonomic dysfunction in multiple sclerosis. Auton Neurosci 193:1\u20136. https:\/\/doi.org\/10.1016\/j.autneu.2015.06.001","journal-title":"Auton Neurosci"},{"key":"611_CR84","doi-asserted-by":"publisher","unstructured":"Crnosija L, Krbot Skoric M, Andabaka M, Junakovic A, Martinovic V, Ivanovic J, Mesaros S, Pekmezovic T, Drulovic J, Habek M (2019) Autonomic dysfunction in people with neuromyelitis optica spectrum disorders. Mult Scler J. https:\/\/doi.org\/10.1177\/1352458519837703","DOI":"10.1177\/1352458519837703"},{"key":"611_CR85","doi-asserted-by":"publisher","unstructured":"Chai J, Logigian EL (2010) Neurological manifestations of primary Sj\u00f6gren\u2019s syndrome. Curr Opin Neurol 23(5):509\u2013513. https:\/\/doi.org\/10.1097\/WCO.0b013e32833de6ab","DOI":"10.1097\/WCO.0b013e32833de6ab"},{"issue":"12","key":"611_CR86","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1136\/annrheumdis-2011-201009","volume":"71","author":"JL Newton","year":"2012","unstructured":"Newton JL, Frith J, Powell D, Hackett K, Wilton K, Bowman S, Price E, Pease C, Andrews J, Emery P, Hunter J, Gupta M, Vadivelu S, Giles I, Isenberg D, Lanyon P, Jones A, Regan M, Cooper A, Moots R, Sutcliffe N, Bombardieri M, Pitzalis C, McLaren J, Young-Min S, Dasgupta B, Griffiths B, Lendrem D, Mitchell S, Ng WF (2012) Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren\u2019s syndrome. Ann Rheum Dis 71(12):1973\u20131979. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201009","journal-title":"Ann Rheum Dis"},{"key":"611_CR87","doi-asserted-by":"publisher","unstructured":"Imrich R, Alevizos I, Bebris L, Goldstein DS, Holmes CS, Illei GG, Nikolov NP (2015) Predominant glandular cholinergic dysautonomia in patients with primary Sj\u00f6gren\u2019s syndrome. Arthr Rheumatol (Hoboken, NJ) 67(5):1345\u20131352. https:\/\/doi.org\/10.1002\/art.39044","DOI":"10.1002\/art.39044"},{"issue":"1","key":"611_CR88","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3904\/kjim.2015.219","volume":"32","author":"JH Koh","year":"2017","unstructured":"Koh JH, Kwok SK, Lee J, Park SH (2017) Autonomic dysfunction in primary Sjogren\u2019s syndrome: a prospective cohort analysis of 154 Korean patients. Kor J Internal Med 32(1):165\u2013173. https:\/\/doi.org\/10.3904\/kjim.2015.219","journal-title":"Kor J Internal Med"},{"issue":"6","key":"611_CR89","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/rheumatology\/ken107","volume":"47","author":"T Mandl","year":"2008","unstructured":"Mandl T, Granberg V, Apelqvist J, Wollmer P, Manthorpe R, Jacobsson LT (2008) Autonomic nervous symptoms in primary Sjogren\u2019s syndrome. Rheumatology (Oxford, England) 47(6):914\u2013919. https:\/\/doi.org\/10.1093\/rheumatology\/ken107","journal-title":"Rheumatology (Oxford, England)"},{"issue":"12","key":"611_CR90","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/qjmed\/hcs172","volume":"105","author":"WF Ng","year":"2012","unstructured":"Ng WF, Stangroom AJ, Davidson A, Wilton K, Mitchell S, Newton JL (2012) Primary Sjogrens syndrome is associated with impaired autonomic response to orthostasis and sympathetic failure. QJM 105(12):1191\u20131199. https:\/\/doi.org\/10.1093\/qjmed\/hcs172","journal-title":"QJM"},{"key":"611_CR91","doi-asserted-by":"publisher","unstructured":"Goodman BP, Crepeau A, Dhawan PS, Khoury JA, Harris LA (2017) Spectrum of autonomic nervous system impairment in Sj\u00f6gren syndrome. Neurol 22(4):127\u2013130. https:\/\/doi.org\/10.1097\/nrl.0000000000000134","DOI":"10.1097\/nrl.0000000000000134"},{"issue":"8","key":"611_CR92","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1177\/0961203318771502","volume":"27","author":"PS Matusik","year":"2018","unstructured":"Matusik PS, Matusik PT, Stein PK (2018) Heart rate variability in patients with systemic lupus erythematosus: a systematic review and methodological considerations. Lupus 27(8):1225\u20131239. https:\/\/doi.org\/10.1177\/0961203318771502","journal-title":"Lupus"},{"issue":"11","key":"611_CR93","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1177\/0961203318783052","volume":"27","author":"PS Matusik","year":"2018","unstructured":"Matusik PS, Matusik PT, Stein PK (2018) Cardiovascular reflex tests in patients with systemic lupus erythematosus: clinical performance and utility. Lupus 27(11):1759\u20131768. https:\/\/doi.org\/10.1177\/0961203318783052","journal-title":"Lupus"},{"issue":"3","key":"611_CR94","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1113\/jp272944","volume":"595","author":"AM Adlan","year":"2017","unstructured":"Adlan AM, Paton JF, Lip GY, Kitas GD, Fisher JP (2017) Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis. J Physiol 595(3):967\u2013981. https:\/\/doi.org\/10.1113\/jp272944","journal-title":"J Physiol"},{"issue":"3","key":"611_CR95","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.semarthrit.2014.06.003","volume":"44","author":"AM Adlan","year":"2014","unstructured":"Adlan AM, Lip GY, Paton JF, Kitas GD, Fisher JP (2014) Autonomic function and rheumatoid arthritis: a systematic review. Semin Arthritis Rheum 44(3):283\u2013304. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.06.003","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"611_CR96","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s10067-014-2716-x","volume":"34","author":"A Syngle","year":"2015","unstructured":"Syngle A, Verma I, Krishan P, Garg N, Syngle V (2015) Disease-modifying anti-rheumatic drugs improve autonomic neuropathy in arthritis: DIANA study. Clin Rheumatol 34(7):1233\u20131241. https:\/\/doi.org\/10.1007\/s10067-014-2716-x","journal-title":"Clin Rheumatol"},{"issue":"3","key":"611_CR97","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.semarthrit.2013.05.002","volume":"43","author":"TN Amaral","year":"2013","unstructured":"Amaral TN, Peres FA, Lapa AT, Marques-Neto JF, Appenzeller S (2013) Neurologic involvement in scleroderma: a systematic review. Semin Arthritis Rheum 43(3):335\u2013347. https:\/\/doi.org\/10.1016\/j.semarthrit.2013.05.002","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"611_CR98","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10067-013-2239-x","volume":"32","author":"A Syngle","year":"2013","unstructured":"Syngle A, Verma I, Garg N, Krishan P (2013) Autonomic dysfunction in psoriatic arthritis. Clin Rheumatol 32(7):1059\u20131064. https:\/\/doi.org\/10.1007\/s10067-013-2239-x","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-019-00611-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10286-019-00611-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-019-00611-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T21:46:21Z","timestamp":1744062381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10286-019-00611-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6,1]]}},"alternative-id":["611"],"URL":"https:\/\/doi.org\/10.1007\/s10286-019-00611-1","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]},"assertion":[{"value":"1 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Golden has no conflict of interest to report. Dr. Vernino has received research support from Grifols, Genentech, Dysautonomia International, and Theravance.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}